BioNTech faces its biggest post pandemic crisis

BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its founders. Can its ambitious cancer trials turn it from a one-hit wonder into a biotech giant?

source https://www.dw.com/en/biontech-faces-its-biggest-post-pandemic-crisis/a-77061364?maca=en-rss-en-ger-1023-rdf